Overview
- The federal health ministry confirmed on Tuesday that four people died of dengue in 2026, with one death each in Michoacán, Veracruz, Tabasco and Oaxaca.
- Official surveillance showed a marked decline from 2025: confirmed cases fell to 2,136 from 3,511, severe cases dropped to 86 from 146, and non‑severe and warning‑sign counts also decreased.
- A Japanese dengue vaccine has received Cofepris sanitary registration and is under review for inclusion in the Compendio Nacional de Insumos for public procurement, while Mexico is partnering with Brazil’s Instituto Butantan on a second vaccine aimed at regional virus genotypes.
- The government is scaling non‑pharmaceutical measures including the community 'Five steps for a home without mosquitoes' campaign, expanded Wolbachia mosquito releases that reduce virus transmission, and plans to add specialized regional labs.
- Large May campaigns reached more than 20 million people and delivered about 8.65 million vaccine doses, a mobilization officials say strengthens surveillance and could accelerate progress toward the administration’s goal to halve dengue, Zika and chikungunya cases by 2030.